AGRX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AGRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-07), Agile Therapeutics's current share price is $0.379. Agile Therapeutics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $54.74. Agile Therapeutics's Cyclically Adjusted PS Ratio for today is 0.01.
The historical rank and industry rank for Agile Therapeutics's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Agile Therapeutics's highest Cyclically Adjusted PS Ratio was 0.19. The lowest was 0.01. And the median was 0.04.
AGRX's Cyclically Adjusted PS Ratio is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Agile Therapeutics's adjusted revenue per share data for the three months ended in Mar. 2024 was $1.234. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $54.74 for the trailing ten years ended in Mar. 2024.
The historical data trend for Agile Therapeutics's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agile Therapeutics Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 0.16 | 0.04 | 0.04 | 0.03 | 0.01 |
For the Drug Manufacturers - Specialty & Generic subindustry, Agile Therapeutics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Agile Therapeutics's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Agile Therapeutics's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Agile Therapeutics's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 0.379 | / | 54.74 | |
= | 0.01 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agile Therapeutics's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Agile Therapeutics's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 1.234 | / | 131.7762 | * | 131.7762 | |
= | 1.234 |
Current CPI (Mar. 2024) = 131.7762.
Agile Therapeutics Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201406 | 0.000 | 100.560 | 0.000 |
201409 | 0.000 | 100.428 | 0.000 |
201412 | 0.000 | 99.070 | 0.000 |
201503 | 0.000 | 99.621 | 0.000 |
201506 | 0.000 | 100.684 | 0.000 |
201509 | 0.000 | 100.392 | 0.000 |
201512 | 0.000 | 99.792 | 0.000 |
201603 | 0.000 | 100.470 | 0.000 |
201606 | 0.000 | 101.688 | 0.000 |
201609 | 0.000 | 101.861 | 0.000 |
201612 | 0.000 | 101.863 | 0.000 |
201703 | 0.000 | 102.862 | 0.000 |
201706 | 0.000 | 103.349 | 0.000 |
201709 | 0.000 | 104.136 | 0.000 |
201712 | 0.000 | 104.011 | 0.000 |
201803 | 0.000 | 105.290 | 0.000 |
201806 | 0.000 | 106.317 | 0.000 |
201809 | 0.000 | 106.507 | 0.000 |
201812 | 0.000 | 105.998 | 0.000 |
201903 | 0.000 | 107.251 | 0.000 |
201906 | 0.000 | 108.070 | 0.000 |
201909 | 0.000 | 108.329 | 0.000 |
201912 | 0.000 | 108.420 | 0.000 |
202003 | 0.000 | 108.902 | 0.000 |
202006 | 0.000 | 108.767 | 0.000 |
202009 | 0.000 | 109.815 | 0.000 |
202012 | 17.023 | 109.897 | 20.412 |
202103 | 2.636 | 111.754 | 3.108 |
202106 | 26.932 | 114.631 | 30.960 |
202109 | 27.383 | 115.734 | 31.179 |
202112 | 25.661 | 117.630 | 28.747 |
202203 | 28.403 | 121.301 | 30.856 |
202206 | 23.622 | 125.017 | 24.899 |
202209 | 4.057 | 125.227 | 4.269 |
202212 | 4.652 | 125.222 | 4.895 |
202303 | 4.181 | 127.348 | 4.326 |
202306 | 3.109 | 128.729 | 3.183 |
202309 | 2.258 | 129.860 | 2.291 |
202312 | 1.216 | 129.419 | 1.238 |
202403 | 1.234 | 131.776 | 1.234 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Agile Therapeutics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Scott M Coiante | officer: Chief Financial Officer | 101 POOR FARM ROAD 3RD FLOOR, PRINCETON NJ 08540 |
Josephine Torrente | director | 101 POOR FARM ROAD, PRINCETON NY 08540 |
Sandra Carson | director | C/O AGILE THERAPEUTICS, INC., 101 POOR FARM ROAD, PRINCETON NJ 08540 |
John W Hubbard | director | 101 POOR FARM ROAD 3RD FLOOR, PRINCETON NJ 08540 |
Fischer Seth H.z. | director | C/O TRIUS THERAPEUTICS, INC., 6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO CA 92121 |
Sharon Surrey Barbari | director | 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080 |
Amy Welsh | officer: Chief Commercial Officer | 500 COLLEGE ROAD EAST, SUITE 310, C/O AGILE THERAPEUTICS, INC., PRINCETON NJ 08540 |
Alfred Altomari | director, officer: Chief Executive Officer | C/O AGILE THERAPEUTICS, INC., 101 POOR FARM ROAD, PRINCETON NJ 08540 |
Perceptive Life Sciences Master Fund Ltd | 10 percent owner | C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Dennis Reilly | officer: Chief Financial Officer | 600 COLLEGE ROAD EAST, PRINCETON NJ 08540 |
Jason Butch | officer: Principal Accounting Officer | 101 POOR FARM ROAD, PRINCETON NJ 08540 |
Paul Korner | officer: Sr. VP & Chief Medical Officer | C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555 |
Abhijeet J Lele | director, See remarks | C/O EP MEDYSTEMS, 575 RTE 73 N, WEST BERLIN NJ 08091 |
Perceptive Advisors Llc | 10 percent owner | 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
Joseph Edelman | 10 percent owner | C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003 |
From GuruFocus
By sperokesalga sperokesalga • 04-28-2023
By ACCESSWIRE • 09-28-2023
By ACCESSWIRE • 07-19-2023
By sperokesalga sperokesalga • 04-26-2023
By ACCESSWIRE • 08-17-2023
By ACCESSWIRE • 06-28-2023
By Marketwired • 06-26-2023
By sperokesalga sperokesalga • 05-25-2023
By sperokesalga sperokesalga • 05-23-2023